TNNT2 and Hyperglycemia: We speculate, that the relationship between subclinical myocardial damage (hs-cTnT), increased coagulability (fibrinogen) and inflammation (hsCRP) may indicate cumulative subclinical CVD risk, associated with hyperglycemia (HbA1c) in Abnl-GT-β-cell failure.